- €1.73bn
- €1.74bn
- €894.52m
- 54
- 42
- 34
- 37
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 855 | 807 | 827 | 863 | 895 |
Cost of Revenue | |||||
Gross Profit | 663 | 635 | 654 | 681 | 682 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 705 | 715 | 821 | 816 | 900 |
Operating Profit | 150 | 92.3 | 5.75 | 46.9 | -5.26 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 128 | 79.2 | -9.09 | 31 | -17.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 106 | 74.3 | -40.9 | 4.28 | -38.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 106 | 74.3 | -40.9 | 4.28 | -38.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 106 | 74.3 | -40.9 | 4.28 | -38.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.382 | 0.46 | 0.119 | 0.051 | -0.045 |